CDKN2A and melanoma: This is consistent with the findings demonstrating a progressive inactivation of the CDKN2A tumor suppressor gene during melanoma progression, which in turn promotes uncontrolled cell proliferation, tumor growth, and increased aggressiveness of tumor cells [9, 11].